Very sorry for IMM holders17 Apr 2018 11:01
I have been watching out of interest, never bought any as I became aware of them after the rise last year and felt I had missed the boat.
I was considering waiting for results and buying some after the inevitable spike and slow retracement.
The market cap over there is now 30-something million which really highlights how cheap Scancell are at 50-odd million.
They have a failed P3 trial, so the value is now in their other candidates which are not as far advanced as SCIB1 and don't show as much promise (IMO).
Not saying IMM are not worth 23p (at time of writing) as they have other drugs in development and may be able to so something with Lupuzor longer term.
Just pointing out how extraordinarily cheap Scancell still are despite recent rises.